Lactobacillus acidophilus modulates intestinal pain and induces opioid and cannabinoid receptors
The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
Abdominal pain is common in the general population and, in patients with irritable bowel syndrome, is attributed to visceral hypersensitivity. We found that oral administration of specific Lactobacillus strains induced the expression of mu-opioid and cannabinoid receptors in intestinal epithelial cells, and mediated analgesic functions in the gut-similar to the effects of morphine. These results suggest that the microbiology of the intestinal tract influences our visceral perception, and suggest new approaches for the treatment of abdominal pain and irritable bowel syndrome.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A few putative mechanisms include: microbial induction of epithelial μ-opioid and cannabinoid receptors as shown with oral administration of Lactobacillus strains in rodents69”
From The gut Microbiome in adult and pediatric functional gastrointestinal disorders (2019) · cites this paper as [69]
In the citing paper
“The use of probiotics, particularly in animal models, also demonstrates that their secreted products or metabolites can modulate contractility of intestinal smooth muscle and visceral sensitivity.59–61”
From Intestinal microbiota in functional bowel disorders: a Rome foundation report (2013) · cites this paper as [60]
In the citing paper
“Interestingly, we saw beneficial effects especially on distension and pain, as this agrees well with the recent findings that certain lactobacilli can induce the expression of pain-sensing receptors in intestinal epithelial cells. 33”
From Clinical trial: multispecies probiotic supplementation alleviates the symptoms of irritable bowel syndrome and stabilizes intestinal microbiota (2008) · cites this paper as [33]
In the citing paper
“In addition, exposure of rats to L. reuteri (83) or L. acidophilus NCFM (151) reduce their pain response to balloon distension, through targeting ion channels in the enteric nervous system (83, 91) or increasing the expression of μ-opioid and cannabinoid receptors in intestinal epithelial cells (151).”
From Intestinal microbiota and immune function in the pathogenesis of irritable bowel syndrome (2013) · cites this paper as [151]
In the citing paper
“Evidence for such mutual interaction has been demonstrated in gut inflammation,14 visceral pain,77 certain symptoms of IBS,12 and in obesity.78”
From Principles and clinical implications of the brain-gut-enteric microbiota axis (2009) · cites this paper as [77]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Gut flora in health and disease
Guarner, F., & Malagelada, J.-R. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12489-0 · Cited by 3,365
O’Mahony, L., McCarthy, J., Kelly, P., Hurley, G., Luo, F., Chen, K., O’Sullivan, G. C., Kiely, B., Collins, J. K., Shanahan, F., et al. (2005) · Gastroenterology · doi:10.1053/j.gastro.2004.11.050 · Cited by 1,448
Falk, P. G., Hooper, L. V., Midtvedt, T., & Gordon, J. I. (1998) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.62.4.1157-1170.1998 · Cited by 657
Attacking pain at its source: new perspectives on opioids
Stein, C., Schäfer, M., & Machelska, H. (2003) · Nature Medicine · doi:10.1038/nm908 · Cited by 608
Complete genome sequence of the probiotic lactic acid bacterium Lactobacillus acidophilus NCFM
Altermann, E., Russell, W. M., Azcarate-Peril, M. A., Barrangou, R., Buck, B. L., McAuliffe, O., Souther, N., Dobson, A., Duong, T., Callanan, M., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409188102 · Cited by 590
Specific probiotic therapy attenuates antibiotic induced visceral hypersensitivity in mice
Verdú, E. F., Bercik, P., Verma-Gandhu, M., Huang, X.-X., Blennerhassett, P., Jackson, W., Mao, Y., Wang, L., Rochat, F., & Collins, S. M. (2006) · Gut · doi:10.1136/gut.2005.066100 · Cited by 448
Cervero, F., & Laird, J. M. (1999) · The Lancet · doi:10.1016/s0140-6736(99)01306-9 · Cited by 434
Invited Review: The Scientific Basis of Lactobacillus acidophilus NCFM Functionality as a Probiotic
Sanders, M. E., & Klaenhammer, T. R. (2001) · Journal of Dairy Science · doi:10.3168/jds.s0022-0302(01)74481-5 · Cited by 433
KAJANDER, K., HATAKKA, K., POUSSA, T., FÄRKKILÄ, M., & KORPELA, R. (2005) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2005.02579.x · Cited by 361
WRIGHT, K., ROONEY, N., FEENEY, M., TATE, J., ROBERTSON, D., WELHAM, M., & WARD, S. (2005) · Gastroenterology · doi:10.1016/j.gastro.2005.05.026 · Cited by 299
Cited by
Items 401–500 of 793
Regulation of body fat mass by the gut microbiota: Possible mediation by the brain
Schéle, E., Grahnemo, L., Anesten, F., Hallén, A., Bäckhed, F., & Jansson, J. (2015) · Peptides · doi:10.1016/j.peptides.2015.03.027 · Cited by 27
The Shortcomings of Clinical Trials Assessing the Efficacy of Probiotics in Irritable Bowel Syndrome
Rogers, N. J., & Mousa, S. A. (2012) · The Journal of Alternative and Complementary Medicine · doi:10.1089/acm.2011.0015 · Cited by 28
Visceral Pain and Psychiatric Disorders
Felice, V. D., Moloney, R. D., Cryan, J. F., Dinan, T. G., & O’Mahony, S. M. (2015) · Modern trends in psychiatry · doi:10.1159/000435936 · Cited by 29
Kahn, J., Pregartner, G., & Schemmer, P. (2020) · Nutrients · doi:10.3390/nu12082461 · Cited by 24
“This mechanism of action has been observed in Lactobacillus acidophilus, and these findings are based on murine models and evidence in humans is still lacking [54].”
BackgroundKanauchi (2010) · International Journal of Molecular Medicine · doi:10.3892/ijmm_00000376 · Cited by 25
Probiotics and Inflammatory Pain: A Literature Review Study
Nazemian, V., Shadnoush, M., Manaheji, H. S., & Zaringhalam, J. (2016) · Middle East Journal of Rehabilitation and Health Studies · doi:10.17795/mejrh-36087 · Cited by 28
“Probiotics can induce the expression of μ and κreceptors in peripheral nerve fibers and increase the number of peripheral nerve terminals in chronically inflamed tissue (72-74) and also can activate and enhance expression of opioid receptors on epithelial cells which locally control the transmission of nociceptive inf…”
BackgroundEmer, A. A., Donatello, N. N., Batisti, A. P., Belmonte, L. A. O., Santos, A. R. S., & Martins, D. F. (2017) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2017.09.011 · Cited by 27
At the heart of microbial conversations: endocannabinoids and the microbiome in cardiometabolic risk
Khan, R. N., Maner-Smith, K. M., Owens, J. A., Barbian, M. E., Jones, R. M., & Naudin, C. R. (2021) · Gut Microbes · doi:10.1080/19490976.2021.1911572 · Cited by 25
Probiotics in luminal gastroenterology: the current state of play
Andrews, J. M., & Tan, M. (2012) · Internal Medicine Journal · doi:10.1111/imj.12015 · Cited by 33
Cannabis and Cannabis Derivatives for Abdominal Pain Management in Inflammatory Bowel Disease
Bogale, K., Raup‐Konsavage, W. M., Dalessio, S., Vrana, K. E., & Coates, M. D. (2021) · Medical Cannabis and Cannabinoids · doi:10.1159/000517425 · Cited by 24
Why Give My Surgical Patients Probiotics
Kotzampassi, K. E. (2022) · Nutrients · doi:10.3390/nu14204389 · Cited by 26
“[46], who first evaluated the ability of five well-known Lactobacilli and Bifidobacteria to induce the expression of analgesic receptors.”
BackgroundCritical Windows: Exploring the Association Between Perinatal Trauma, Epigenetics, and Chronic Pain
Kodila, Z. N., Shultz, S. R., Yamakawa, G. R., & Mychasiuk, R. (2023) · The Neuroscientist · doi:10.1177/10738584231176233 · Cited by 24
“…are known to modify nociceptive perception within the CNS. Administration of Lactobacillus acidophilus increased expression of multiple receptor types within the gut, including μ -opioid and cannabinoid receptors, and regulated analgesic responses in a rodent model (Rousseaux and others 2007).”
BackgroundChai, F., Maton, M., Degoutin, S., Vermet, G., Simon, N., Rousseaux, C., Martel, B., & Blanchemain, N. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.07.032 · Cited by 23
Self-citationLee, K. J. (2021) · Journal of Neurogastroenterology and Motility · doi:10.5056/jnm21042 · Cited by 25
Yang, F., Zhu, W., Edirisuriya, P., Ai, Q., Nie, K., Ji, X., Li, Y., & Zhou, K. (2021) · Nutrition · doi:10.1016/j.nut.2021.111439 · Cited by 22
Aguilera, M., Vergara, P., & Martínez, V. (2013) · Microbial Ecology · doi:10.1007/s00248-013-0241-0 · Cited by 28
“This partially agrees with previous reports in which gut microbiota was related with the content of MOR and CB2 receptors in the gut, leading to an analgesia-like state [29].”
InfluentialVisceral analgesics: drugs with a great potential in functional disorders?☆
Bradesi, S., HERMAN, J., & Mayer, E. A. (2008) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2008.08.009 · Cited by 24
Evolving Knowledge of Opioid Genetics in Cancer Pain
Droney, J., Riley, J. L., & Ross, J. R. (2011) · Clinical Oncology · doi:10.1016/j.clon.2011.04.015 · Cited by 22
“There is a large number of other clinical and environmental factors that have been shown to influence pain perception or opioid response, including psychological state (anxiety and depression) [85,86], social status and diet [87].”
BackgroundMicrobiota Involvement in the Gut–Brain Axis
Indrio, F., Riezzo, G., Raimondi, F., Mauro, A. D., & Francavilla, R. (2013) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/01.mpg.0000441927.20931.d6 · Cited by 24
“It is now known that specific microbes alter pain pathways in the intestine, inducing the expression of opioid and cannabinoid receptors in intestinal epithelial cells and mediating analgesic functions in the gut, similar to the effects of morphine (35).”
BackgroundHughes, P., Costello, S., Bryant, R., & Andrews, J. (2016) · American Journal of Physiology - Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00442.2015 · Cited by 23
“Finally, while there is some evidence outlined above that epithelial cells express opioid receptors [MOR (89), DOR (112)], direct evidence that the expression of opioid receptors on immune cells is involved in diseases of the lower GI tract is lacking.”
BackgroundNutritional Modulators of Pain in the Aging Population
Smithson, J. A. J., Kellick, K. A., & Mergenhagen, K. A. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-805186-3.00016-3 · Cited by 22
Probiotics in digestive, emotional, and pain-related disorders
Román, P., Abalo, R., Marco, E. M., & Cardona, D. (2018) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000385 · Cited by 28
“, 2010a, 2010b), and up-regulated mu-opioid and cannabinoid receptors expression, in rats and mice, leading to visceral analgesia (Rousseaux et al., 2007).”
BackgroundInfluentialMolecular mechanisms of probiotic action: it's all in the strains!
Shanahan, F. (2011) · Gut · doi:10.1136/gut.2011.241026 · Cited by 21
“Curiously, the anti-inflammatory L salivarius Ls33 and the non-protective L acidophilus NCFM strains used by Fernandez et al have previously been studied in a model of visceral hyperalgesia whereby the latter strain appeared to have greater anti-nociceptive capacity than the former.(11) The contrasting results with di…”
ResultThe significance of the gut microbiome in children with functional constipation
Kwiatkowska, M., & Krogulska, A. (2021) · Advances in Clinical and Experimental Medicine · doi:10.17219/acem/131215 · Cited by 22
Terán-Ventura, E., Roca, M., Martín, M. T., Abarca, M. L., Martínez, V., & Vergara, P. (2010) · Microbial Ecology · doi:10.1007/s00248-010-9737-z · Cited by 27
“This agrees with a growing body of evidence implicating the commensal microbiota as an experimental factor influencing the outcome of both digestive and extra-digestive studies in animals [8, 31, 41, 43, 44].”
BackgroundReview: Effect of probiotics on gastrointestinal function: evidence from animal models
Verdú, E. F., Bercik, P., & Collins, S. M. (2009) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756283x09337645 · Cited by 22
“Other groups using different probiotic strains have also demonstrated an impact of probiotic therapy on visceral and pain perception [Rousseaux et al. 2007; Eutamene et al. 2007].”
Background(2013) · PubMed
Close association between intestinal microbiota and irritable bowel syndrome
Fan, W.-T., Ding, C., Xu, N., Zong, S., Ma, P., & Gu, B. (2017) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-017-3060-2 · Cited by 25
Pourmasoumi, M., Ghiasvand, R., Darvishi, L., Hadi, A., Bahreini, N., & Keshavarzpour, Z. (2018) · EXPLORE · doi:10.1016/j.explore.2018.09.003 · Cited by 23
Metabolomics: The Key to Unraveling the Role of the Microbiome in Visceral Pain Neurotransmission
Shute, A., Bihan, D. G., Lewis, I. A., & Nasser, Y. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.917197 · Cited by 23
Effects of β-(1,3–1,6)-d-glucan on irritable bowel syndrome-related colonic hypersensitivity
Asano, T., Tanaka, K., Suemasu, S., Ishihara, T., Tahara, K., Suzuki, T., Suzuki, H., Fukudo, S., & Mizushima, T. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.03.015 · Cited by 20
Cannabinoid Receptors in Regulating the GI Tract: Experimental Evidence and Therapeutic Relevance
Taschler, U., Hasenoehrl, C., Storr, M., & Schicho, R. (2016) · Handbook of experimental pharmacology · doi:10.1007/164_2016_105 · Cited by 21
The Potential Influence of the Microbiota and Probiotics on Women during Long Spaceflights
Urbaniak, C., & Reid, G. (2016) · Women s Health · doi:10.2217/whe.15.101 · Cited by 23
Probiotics in irritable bowel syndrome: an immunomodulatory strategy?
Quigley, E. M. M. (2007) · Journal of the American College of Nutrition · doi:10.1080/07315724.2007.10719648 · Cited by 19
“Most recently, Rousseaux and colleagues found that oral administration of specific Lactobacillus strains induced the expression of mu-opioid and cannabinoid receptors in intestinal epithelial cells and mediated analgesic functions in the gut-similar to the effects of morphine [78].”
BackgroundThe characteristics of intestinal flora of IBS‐D with different syndromes
Chao, G., & Zhang, S. (2020) · Immunity Inflammation and Disease · doi:10.1002/iid3.348 · Cited by 22
“Rousseaux et al.(27) put forward the inference that probiotics were involved in regulating intestinal sensitivity that lactobacillus acidophilus could induce the expression of opioid receptors and cannabinoid receptors on intestinal mucosa epithelial cells.”
BackgroundCannabinoids and Endocannabinoid System Changes in Intestinal Inflammation and Colorectal Cancer
Cherkasova, V., Kovalchuk, O., & Kovalchuk, I. (2021) · Cancers · doi:10.3390/cancers13174353 · Cited by 20
“The addition of the probiotic Lactobacillus acidophilus has been associated with increased expression of enterocytic CB2 receptors in treated animals [92,126].”
BackgroundProbiotics in Irritable Bowel Syndrome: A Review Article
Sharma, S., Kumar, S., Sajjad, S., & Sharma, S. (2023) · Cureus · doi:10.7759/cureus.36565 · Cited by 21
“Lactobacillus acidophilus boosted the expression of m-opioid and cannabinoid receptors in colonic epithelial cell lines [24].”
BackgroundShanahan, F. (2010) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2010.04135.x · Cited by 19
“and exploitation Rousseaux et al. (2007) [37] 99 DAHLEM CONFERENCE F.”
BackgroundMeijerink, M., Mercenier, A., & Wells, J. M. (2013) · Beneficial Microbes · doi:10.3920/bm2012.0035 · Cited by 21
“, 2002; Yan and Polk, 2002), while some nonreplicating probiotics may retain their capacity to impact the host immune system, depending on the strain and inactivation method (Rachmilewitz et al., 2004; Rousseaux et al., 2007).”
BackgroundProbiotic fermented foods and health promotion
Ouwehand, A. C., & Röytiö, H. (2014) · Elsevier eBooks · doi:10.1016/b978-1-78242-015-6.00001-3 · Cited by 24
Self-citationTargeting the endocannabinoid system for gastrointestinal diseases: future therapeutic strategies
Schicho, R., & Storr, M. (2010) · Expert Review of Clinical Pharmacology · doi:10.1586/ecp.09.62 · Cited by 21
Fabbro, L. D., Filho, C. B., Souza, L. C., Savegnago, L., Alves, D. A. C., Schneider, P. H., de Salles, H. D., & Jessé, C. R. (2012) · Brain Research · doi:10.1016/j.brainres.2012.08.008 · Cited by 22
“…with the cannabinoid receptors, animals were pretreated with the selective CB1 receptor antagonist AM251; (1 mg/kg, intraperitoneally i.p.), (Liu and Walker, 2006), or the selective CB2 receptor antagonist AM630; (3 mg/kg i.p.), (Rousseaux et al., 2007), 30 min before Se-PTC (25 mg/kg, p.o.).”
Why chronic cough in children is different
Kantar, A., & Seminara, M. (2019) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2019.03.001 · Cited by 25
Chen, Y., Li, Y., Wang, X., Wang, Z., Hou, J., Su, S., Zhong, W., Xu, X. J., Zhang, J., Wang, B., et al. (2022) · World Journal of Gastroenterology · doi:10.3748/wjg.v28.i5.532 · Cited by 19
Development of probiotic products for nutritional requirements of specific human populations
Arboleya, S., González, S., Salazar, N., Ruas‐Madiedo, P., Reyes‐Gavilán, C. G. D. L., & Gueimonde, M. (2012) · Engineering in Life Sciences · doi:10.1002/elsc.201100129 · Cited by 19
Challenges and prospects for pharmacotherapy in functional gastrointestinal disorders
Sanger, G. J., Chang, L., Bountra, C., & Houghton, L. A. (2010) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756283x10369922 · Cited by 17
“A particularly interesting animal study is the demonstration that oral administration of Lactobacillus acidophilus reduced butyrate-induced hyperalgesia in rats, to a level approximately similar to that of a single dose of morphine (1 mg/kg sc) [Rousseaux et al. 2007].”
ResultProbiotics in Functional Dyspepsia
Tziatzios, G., Gkolfakis, P., Leite, G., Mathur, R., Damoraki, G., Giamarellos‐Bourboulis, E. J., & Τriantafyllou, Κ. (2023) · Microorganisms · doi:10.3390/microorganisms11020351 · Cited by 21
“Nonetheless, the mechanism of action of probiotics in improving IBS symptoms remains unknown, with the ability to modify the expression of gut pain receptors or normalization in the interleukin levels being reported as potential ones [13,14].”
BackgroundYuan, W., Xiao, J., Liao, H., Xie, Z., Zhao, Y. V., Li, C., Zhou, K., & Song, X. (2023) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2023.1207911 · Cited by 18
“, 2017) and could be activated by some specific Lactobacillus strains in vitro (Rousseaux et al., 2007).”
BackgroundLüdtke, D. D., Siteneski, A., Galassi, T. D. O., Buffon, A. C., Cidral‐Filho, F. J., Reed, W. R., Salgado, A. S. I., Santos, A. R. S., & Martins, D. F. (2020) · Scandinavian Journal of Medicine and Science in Sports · doi:10.1111/sms.13705 · Cited by 21
Hegde, S., Lin, Y.-M., Fu, Y., Savidge, T., & Shi, X.-Z. P. (2020) · Pain · doi:10.1097/j.pain.0000000000001967 · Cited by 19
“earlier studies reported that Lactobacillus acidophilus was also able to induce MOR expression in the colon.(58,62) These discoveries that Lactobacillus increases expression of peripheral”
ResultQi, Q., Liu, H., Yang, Y., Wang, Y., Xia, C., Tian, P., Wei, J., Li, S., & Chen, T. (2021) · Disease Markers · doi:10.1155/2021/5597401 · Cited by 27
RetractedAbdrabou, A. M., Osman, E. Y., & Aboubakr, O. A. (2018) · Human Microbiome Journal · doi:10.1016/j.humic.2018.08.001 · Cited by 19
The endocannabinoid system: a bridge between alzheimer’s disease and gut microbiota
Bisogno, T., Lauritano, A., & Piscitelli, F. (2021) · Life · doi:10.3390/life11090934 · Cited by 16
Kiron, V., Hayes, M., & Avni, D. (2022) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2022.09.012 · Cited by 17
The emerging role of the endocannabinoidome-gut microbiome axis in eating disorders
Mir, H.-D., Giorgini, G., & Marzo, V. D. (2023) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2023.106295 · Cited by 17
Yin, Z., Wang, K., Liu, Y., Li, Y., He, F., Yin, J., & Tang, W. (2024) · Animals · doi:10.3390/ani14030493 · Cited by 20
He, J., Ruan, W., Sun, J., Wang, F., & Yan, W. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.01935 · Cited by 16
“acidophilus can alleviate lactose intolerance (Kim and Gilliland, 1983), abdominal pain, and irritable bowel syndrome (Rousseaux et al., 2007) as well as modulate dendritic and T cell function (Konstantinov et al.”
BackgroundSzymaszkiewicz, A., Storr, M., Fichna, J., & Zielińska, M. (2018) · Neurogastroenterology & Motility · doi:10.1111/nmo.13526 · Cited by 18
Irritable Bowel Syndrome: Manipulating the Endocannabinoid System as First-Line Treatment
Brugnatelli, V., Turco, F., Freo, U., & Zanette, G. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00371 · Cited by 16
Effects of probiotics on pentylenetetrazol-induced convulsions in mice
Sabouri, S., Kangi, S., Najimi, S., & Rahimi, H. R. (2021) · Epilepsy Research · doi:10.1016/j.eplepsyres.2021.106723 · Cited by 17
The Intestinal Microbiota and Probiotics
Forssten, S. D., Lahtinen, S. J., & Ouwehand, A. C. (2011) · Springer eBooks · doi:10.1007/978-94-007-0386-5_2 · Cited by 24
“…cells and the epithelial cells are not the only host cells which can be directly affected by gut microbes and probiotics; probiotic strain L. acidophilus NCFM has recently S. D. Forssten et al. 53 been shown to be able to interact directly also with host pain receptors (Rousseaux et al. 2006).”
BackgroundSelf-citationKonar, N., Palabıyık, İ., Toker, Ö. S., Polat, D. G., Sener, S., Akçiçek, A., & Sağdıç, O. (2017) · International Journal of Food Engineering · doi:10.1515/ijfe-2017-0045 · Cited by 16
New Options in Constipation Management
Davis, M. P., & Gamier, P. (2015) · Current Oncology Reports · doi:10.1007/s11912-015-0481-x · Cited by 17
The Efficacy of Probiotics in IBS
Quigley, E. M. M. (2008) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e31816244ca · Cited by 16
Singh, S., Abu, Y. F., Antoine, D., Gomez, D., Tao, J., Truitt, B., & Roy, S. (2025) · Gut Microbes · doi:10.1080/19490976.2025.2464942 · Cited by 17
The role of intestinal microbiota in the pathogenesis of metabolic diseases
Węgielska, I., & Suliburska, J. (2016) · Acta Scientiarum Polonorum Technologia Alimentaria · doi:10.17306/j.afs.2016.2.20 · Cited by 18
Probiotics in Postoperative Pain Management
Fyntanidou, B., Amaniti, A., Soulioti, E., Zagalioti, S., Gkarmiri, S., Chorti, A. G., Loukipoudi, L., Ioannidis, A., Dalakakis, I., Menni, A.-E., et al. (2023) · Journal of Personalized Medicine · doi:10.3390/jpm13121645 · Cited by 17
“…reuteri DSM 17938 treatment significantly alters the mRNA levels of the transcription factors retinoid-related orphan receptor-γ (ROR γ ) and forkhead box P3 (FOXP3) in the peripheral blood, which modulate T-cell responses to gut microbes: it increases the FOXP3 concentration, thus…”
BackgroundInfluentialCannabis use in the United States and its impact on gastrointestinal health
Alshaarawy, O., Balasubramanian, G., & Venkatesan, T. (2023) · Nutrition in Clinical Practice · doi:10.1002/ncp.11111 · Cited by 23
“103 Probiotic treatment increased AEA in the jejunum, whereas antibiotics reduced its levels in the duodenum.”
The Endocannabinoid System: Implications in Gastrointestinal Physiology and Pathology
Caruso, E. A., Nunzio, V. D., Tutino, V., & Notarnicola, M. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26031306 · Cited by 18
Sadrin, S., Sennoune, S. R., Gout, B., Marque, S., Moreau, J., Grillasca, J., Pons, O., & Maixent, J. M. (2017) · Cellular and Molecular Biology · doi:10.14715/cmb/2017.63.9.21 · Cited by 15
Dargenio, V. N., Cristofori, F., Dargenio, C., Giordano, P., Indrio, F., Celano, G., & Francavilla, R. (2022) · Beneficial Microbes · doi:10.3920/bm2021.0151 · Cited by 18
Probiotics and Oxidative Stress
Kullisaar, T., Songisepp, E., & Zilmer, M. (2012) · InTech eBooks · doi:10.5772/33924 · Cited by 20
“Special probiotic strains may induce the expression of receptors on epithelial cells that locally control the transmission of nociceptive information to the GI nervous system (Rousseaux et al., 2007).”
BackgroundFrom Active Ingredients to the Discovery of the Targets: The Cannabinoid Receptors
Mackie, K. (2007) · Chemistry & Biodiversity · doi:10.1002/cbdv.200790148 · Cited by 17
GASTROINTESTINAL ENDOCANNABINOID SYSTEM: MULTIFACETED ROLES IN THE HEALTHY AND INFLAMED INTESTINE
Smid, S. D. (2008) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2008.05016.x · Cited by 17
“Interestingly, CB2 receptors have been implicated in the analgesia associated with colorectal distension following probiotic administration in rats.(67) Despite such studies, the disposition of either CB1 or CB2 receptors to sensory nerves in the human bowel has yet to be characterized.”
BackgroundIn the Beginning Was Helicobacter pylori: Roles for Microbes in Other Intestinal Disorders
Hecht, G. A. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.01.013 · Cited by 15
Mao, M., Zhou, Y., Jiao, Y., Yin, S., Cheung, C., Yu, W., Gao, P., & Yang, L. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.975376 · Cited by 14
“The paper published in Nature Medicine had the highest average citation per paper, which discovered that oral administration of Lactobacillus acidophilus induced the expression of μ-opioid and cannabinoid receptors and mediated analgesic effects (26).”
BackgroundInfluentialNon-pharmacologic approaches to treatment of pediatric functional abdominal pain disorders
Chakraborty, P. S., Daniel, R. C., & Navarro, F. A. (2023) · Frontiers in Pediatrics · doi:10.3389/fped.2023.1118874 · Cited by 27
Altered microbiome and metabolome profiling in fearful companion dogs: An exploratory study
Sacchettino, L., Costanzo, M., Veneruso, I., D’Argenio, V., Mayer, M., Avallone, L., Napolitano, F., & d’Angelo, D. (2025) · PLoS ONE · doi:10.1371/journal.pone.0315374 · Cited by 14
Meta-analysis of the efficacy of probiotics to treat diarrhea
Wang, F., Zhao, T., Wang, W., Dai, Q., & Ma, X. (2022) · Medicine · doi:10.1097/md.0000000000030880 · Cited by 14
Colorectal sensation and motility
Gudsoorkar, V. S., & Quigley, E. M. M. (2013) · Current Opinion in Gastroenterology · doi:10.1097/mog.0000000000000028 · Cited by 14
“Furthermore, Bifidobacteria have been shown to reduce visceral pain [80] and certain Lactobacilli to induce expression of opioid and cannabinnoid receptors and, thereby, modulate visceral pain [81].”
BackgroundWhat is the evidence for the use of probiotics in functional disorders?
Quigley, E. M. M. (2008) · Current Gastroenterology Reports · doi:10.1007/s11894-008-0072-1 · Cited by 14
Probiotic Products in Canada with Clinical Evidence: What Can Gastroenterologists Recommend?
Reid, G., Anukam, K. C., & Koyama, T. E. (2008) · Canadian Journal of Gastroenterology · doi:10.1155/2008/843892 · Cited by 15
“translocate the gut wall and produce substances that affect pain receptors (3-6), it seems reasonable to attempt to manipulate the composition of these organisms through the ingestion of beneficial ones.”
BackgroundChronic abdominal pain in irritable bowel syndrome – current and future therapies
Zielińska, A., Sałaga, M., Włodarczyk, M., & Fichna, J. (2018) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2018.1494571 · Cited by 18
“demonstrated interesting results linking certain strains of bacteria to the CB2 and MOR receptors [65].”
BackgroundAlmansa, C., Agrawal, A. K., & Houghton, L. A. (2012) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/egh.12.9 · Cited by 14
Inflammasome Signaling Regulates the Microbial–Neuroimmune Axis and Visceral Pain in Mice
Aguilera, M., Rossini, V., Hickey, A., Simnica, D., Grady, F., Felice, V. D., Moloney, A., Pawley, L. C., Fanning, A., McCarthy, L., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22158336 · Cited by 13
Reid, G. (2011) · BioEssays · doi:10.1002/bies.201100074 · Cited by 13
Khoo, S. C., Zhang, N., Luang‐In, V., Goh, M. S., Sonne, C., & Ling, N. (2024) · Environmental Research · doi:10.1016/j.envres.2024.118441 · Cited by 14
Xu, M., Zhang, W., Lin, B., Lei, Y., Zhang, Y., Zhang, Y., Chen, B., Mao, Q., Kim, J. J., & Cao, Q. (2024) · Nutrition Reviews · doi:10.1093/nutrit/nuae022 · Cited by 14
Umeano, L., Iftikhar, S., Alhaddad, S. F., Paulsingh, C. N., Riaz, M. F., Garg, G., & Mohammed, L. (2024) · Cureus · doi:10.7759/cureus.58306 · Cited by 18
“These findings highlight the potential therapeutic impact of probiotics on GI discomfort and hypersensitivity in various populations [22].”
BackgroundEndocannabinoid system in irritable bowel syndrome and cannabis as a therapy
Pandey, S., Kashif, S., Youssef, M., Sarwal, S., Zraik, H., Singh, R., & Rutkofsky, I. H. (2019) · Complementary Therapies in Medicine · doi:10.1016/j.ctim.2019.102242 · Cited by 15
Jacouton, E., Mondot, S., Langella, P., & Bermúdez‐Humarán, L. G. (2023) · Bioengineering · doi:10.3390/bioengineering10101151 · Cited by 16
“Several health benefits have been attributed to LAB (mainly lactobacilli strains), including the regulation of the host immune response and the epithelial barrier homeostasis, as well as the modulation of the gut microbiota and metabolic functions [7–11].”
BackgroundProbiotics and Irritable Bowel Syndrome
Korpela, R., & Niittynen, L. (2012) · Microbial Ecology in Health and Disease · doi:10.3402/mehd.v23i0.18573 · Cited by 19
“acidophilus NCFM was able to increase the visceral pain threshold in rats and to upregulate m-opioid and cannabinoid receptors in colonic epithelial cells and in the colonic epithelium of rodents (49).”
BackgroundIrritable Bowel Syndrome in Terms of Changes in the Microbiota
Ivashkin, V. T., & Zolnikova, O. Y. (2019) · Russian Journal of Gastroenterology Hepatology Coloproctology · doi:10.22416/1382-4376-2019-29-1-84-92 · Cited by 14
ALIMENTOS PROBIÓTICOS EN CHILE: ¿QUÉ CEPAS Y QUÉ PROPIEDADES SALUDABLES?
Cáceres, P., & Martín Gotteland, R. (2010) · Revista chilena de nutrición · doi:10.4067/s0717-75182010000100010 · Cited by 14
Bai, T., Zhang, L., Wang, H., Qian, W., Song, J., & Hou, X. (2018) · BioMed Research International · doi:10.1155/2018/3860743 · Cited by 16
“acidophilus was indicated to upregulateμ-opioid and cannabinoid receptors in vitro and in vivo [11].”
BackgroundOpioid Use and Gut Dysbiosis in Cancer Pain Patients
Coluzzi, F., Scerpa, M. S., Loffredo, C., Borro, M., Pergolizzi, J. V., LeQuang, J. A., Alessandri, E., Simmaco, M., & Rocco, M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25147999 · Cited by 16
“Particularly, Lactobacillus was found to induce the expression of mu-opioid receptors in intestinal epithelial cells [113] and in the spinal cord [114].”
BackgroundKhodadoostan, M., Shavakhi, A., Sherafat, Z., & Shavakhi, A. (2018) · Advanced Biomedical Research · doi:10.4103/abr.abr_216_17 · Cited by 12
“Other studies have proven the positive effect of probiotic materials on the decrease of pain.[24,25] Abdominal pain is one of the most common symptoms among IBS patients.”
Oral Phyto-thymol ameliorates the stress induced IBS symptoms
Subramaniyam, S., Yang, S., Diallo, B. N., Xu, F., Luo, L., Li, C., Bishop, Ö. T., & Bhattacharyya, S. (2020) · Scientific Reports · doi:10.1038/s41598-020-70420-4 · Cited by 12
Zeng, Z., Zeng, X., Guo, Y., Wu, Z. F., Cai, Z., & Pan, D. (2022) · Foods · doi:10.3390/foods11121719 · Cited by 12
“It has been reported to improve intestinal flora composition [3], regulate metabolism levels [4], enhance immune function, and also prevent cancer [5].”
BackgroundCannabis and Endometriosis: The Roles of the Gut Microbiota and the Endocannabinoid System
Farooqi, T., Bhuyan, D. J., Low, M., Sinclair, J., Leonardi, M., & Armour, M. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12227071 · Cited by 13
“The administration of Lactobacillus acidophilus in mice led to an increase in CB 2 expression in intestinal epithelial cells, resulting in analgesic effects, thus decreasing visceral pain [89].”
Background
Metadata
- Authors
- Rousseaux, C., Thuru, X., Gelot, A., Barnich, N., Neut, C., Dubuquoy, L., Dubuquoy, C., Merour, E., Geboes, K., Chamaillard, M., Ouwehand, A., Leyer, G., Carcano, D., Colombel, J.-F., Ardid, D., & Desreumaux, P.
- Affiliations
- Inserm (FR)
- Université Clermont Auvergne (FR)
- KU Leuven (BE)
- Corresponding author
- Desreumaux, Pierre
- ORCID
- Venue
- Nature Medicine
- Published
- 2006-12-10
- Volume
- 13
- Issue
- 1
- Pages
- 35-37
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W1966470298
- Cited by
- 793
- References
- 16
- Citations by year
- 2026: 15 · 2025: 28 · 2024: 38 · 2023: 46 · 2022: 44 · 2021: 48 · 2020: 42 · 2019: 50 · 2018: 53 · 2017: 40 · 2016: 42 · 2015: 34 · 2014: 47 · 2013: 58 · 2012: 44
- FWCI
- 26.03
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Medicine (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Topics
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Keywords
- Lactobacillus acidophilus, intestinal pain, abdominal pain, irritable bowel syndrome, visceral hypersensitivity, mu-opioid receptor, cannabinoid receptors, intestinal epithelial cells, gut microbiota, analgesia, probiotics
- MeSH terms
- Administration, Oral, Analgesics, Opioid, Animals, Colon, Dose-Response Relationship, Drug, Humans, Indoles, Intestines, Lactobacillus acidophilus, Male, Mice, Inbred BALB C, Morphine, Naloxone, Narcotic Antagonists, Receptors, Opioid, Rectum, Abdominal Pain, Rats, Sprague-Dawley, Receptors, Opioid, mu, HT29 Cells, Probiotics, Receptors, Cannabinoid, Receptor, Cannabinoid, CB2, Mice, Rats, Cannabinoid Receptor Antagonists
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.